These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 18524992

  • 1. Deficiency of decay-accelerating factor and complement receptor 1-related gene/protein y on murine platelets leads to complement-dependent clearance by the macrophage phagocytic receptor CRIg.
    Kim DD, Miwa T, Kimura Y, Schwendener RA, van Lookeren Campagne M, Song WC.
    Blood; 2008 Aug 15; 112(4):1109-19. PubMed ID: 18524992
    [Abstract] [Full Text] [Related]

  • 2. Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor.
    Molina H, Miwa T, Zhou L, Hilliard B, Mastellos D, Maldonado MA, Lambris JD, Song WC.
    Blood; 2002 Dec 15; 100(13):4544-9. PubMed ID: 12393518
    [Abstract] [Full Text] [Related]

  • 3. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
    Miwa T, Zhou L, Hilliard B, Molina H, Song WC.
    Blood; 2002 May 15; 99(10):3707-16. PubMed ID: 11986227
    [Abstract] [Full Text] [Related]

  • 4. Deletion of Crry and DAF on murine platelets stimulates thrombopoiesis and increases factor H-dependent resistance of peripheral platelets to complement attack.
    Barata L, Miwa T, Sato S, Kim D, Mohammed I, Song WC.
    J Immunol; 2013 Mar 15; 190(6):2886-95. PubMed ID: 23390291
    [Abstract] [Full Text] [Related]

  • 5. Retrovirus-mediated over-expression of decay-accelerating factor rescues Crry-deficient erythrocytes from acute alternative pathway complement attack.
    Kim DD, Miwa T, Song WC.
    J Immunol; 2006 Oct 15; 177(8):5558-66. PubMed ID: 17015743
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens.
    Helmy KY, Katschke KJ, Gorgani NN, Kljavin NM, Elliott JM, Diehl L, Scales SJ, Ghilardi N, van Lookeren Campagne M.
    Cell; 2006 Mar 10; 124(5):915-27. PubMed ID: 16530040
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.
    Sohn JH, Kaplan HJ, Suk HJ, Bora PS, Bora NS.
    Invest Ophthalmol Vis Sci; 2000 Oct 10; 41(11):3492-502. PubMed ID: 11006244
    [Abstract] [Full Text] [Related]

  • 16. Complement receptor of the Ig superfamily enhances complement-mediated phagocytosis in a subpopulation of tissue resident macrophages.
    Gorgani NN, He JQ, Katschke KJ, Helmy KY, Xi H, Steffek M, Hass PE, van Lookeren Campagne M.
    J Immunol; 2008 Dec 01; 181(11):7902-8. PubMed ID: 19017980
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phenotypic and functional profiles of CRIg (Z39Ig)-expressing macrophages in the large intestine.
    Tanaka M, Nagai T, Usami M, Hasui K, Takao S, Matsuyama T.
    Innate Immun; 2012 Apr 01; 18(2):258-67. PubMed ID: 21768202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.